The groups of Davis, Mousa and Hercbergs provided first examples and demonstrated that tetrac, which inhibits TH action at αvβ3, reduces growth of medullary thyroid cancer cells and renal cancer cells in mouse xenograft models [34,35]. Here, TH is linked to medullary thyroid gland carcinoma.